LabAutomation 2006 - SLAS
LabAutomation 2006 - SLAS
LabAutomation 2006 - SLAS
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Where Laboratory Technologies Emerge and Merge<br />
11:00 am Tuesday, January 24, <strong>2006</strong> Track 2: Micro- and Nanotechnologies Room: Pasadena<br />
Wyndham Palm Springs Hotel<br />
Achim Wixforth<br />
University of Augsburg<br />
Augsburg, Germany<br />
achim.wixforth@physik.uni-augsburg.de<br />
F I N A L I S T<br />
Acoustically Driven Programmable Microfluidics for Biological and Chemical Applications<br />
A novel approach towards the needs of a versatile microfluidic chip-based microfluidic system with unique properties and functionality<br />
is presented. Like for microarrays and in contrast to many existing microfluidic technologies, the fluid handling is performed on the flat<br />
surface of a programmable chip, where fluidic tracks and functional blocks such as valves, dispensers, mixers, and sensing elements are<br />
chemically defined using standard lithographic techniques. The actuation of the fluid, the driving and adressing of the functional elements<br />
as well as possible sensors are based on electrically excited mechanical acoustic waves, propagating along the surface of a chip. The<br />
combination of such fluidic networks and our unique pumping technology results in fully programmable microfluidic processor chips. The<br />
whole system has no moving parts, and is easily fabricated employing standard semiconductor technologies. Moreover, due to the planar<br />
nature of the chip all functional blocks are readily accessible from the outside, e.g., by pipettes or spotting robots. This unique feature<br />
makes our programmable fluidic processors fully compatible to existing laboratory environments and most any chemical and biological<br />
processes and assays.<br />
Typical areas for the application of this novel technology are the hybridization of DNA or proteomic microarrays, on-chip polymerase chain<br />
reactions, and cell assays, where single cell manipulation at the planar surface of a chip can be performed. Apart from giving a detailed<br />
introduction to the basics of our technology we present a variety of different applications.<br />
11:30 am Tuesday, January 24, <strong>2006</strong> Track 2: Micro- and Nanotechnologies Room: Pasadena<br />
Wyndham Palm Springs Hotel<br />
Scott Mosser<br />
Co-Author(s)<br />
Merck And Company<br />
John Fay<br />
West Point, Pennsylvania<br />
Wei Lemarie<br />
scott_mosser@merck.com<br />
Thomas Harkins<br />
Kenneth Koblan<br />
Stefanie Kane<br />
Rodney Bednar<br />
A Critical Evaluation of the Mosquito (A Low Volume Liquid Handler): A Tool for Drug<br />
Discovery<br />
The preparation of plates for primary and secondary screening requires the application of sophisticated liquid handling equipment to<br />
cope with the range of dispensation volumes and assay formats. The Mosquito is a low volume (0.05 to 1.2 uL) pipettor that uses<br />
positive-displacement, disposable tips to aspirate and dispense liquids. This instrument, made by TTP LabTech (http://www.ttplabtech.<br />
com/mosquito), has a number of unique features and applications for the drug discovery process. For instance, it can facilitate the<br />
miniaturization of assays by allowing for serial dilutions on a microliter scale and the creation of assay ready drug plates.<br />
This talk will discuss the uses of the Mosquito in the drug discovery workflow and provide a critical evaluation of the instrument. The<br />
incorporation of the Mosquito into our drug discovery process has made a direct impact on workflow efficiency and productivity in our<br />
laboratory. This low volume liquid handler has given us the ability to remove unnecessary work, reduce the volumes of costly reagents and<br />
waste, and conserve on valuable compound. In addition, it has enabled lowering of DMSO concentrations in sensitive assays, provided low<br />
volume assay ready plates and maintained the accuracy and precision of our dose inhibition curves.<br />
65